Verastem, Inc.

Verastem, Inc. - Enterprise Valueverified

2VSA.F

Price:

$4.836

Market Cap:

$417.96M

Verastem, Inc. is a biopharmaceutical firm in its development phase, concentrating on the advancement and market introduction of therapeutic agents for oncological conditions. A primary investigational compound is VS-6766 (also known as avutometinib). This agent functions as a RAF/MEK clamp, impeding MEK kinase activity and the capacity of RAF to phosphorylate MEK. Its pipeline includes RAMP 201, an adaptive, two-part, multicenter, parallel cohort, randomized, open-label clinical trial. This study assesses the effectiveness and safety of avutometinib, both as a standalone treatment and in conjunction with defactinib, an oral small molecule inhibitor of focal adhesion kinase (FAK), for indivi...[Read more]

Industry

Biotechnology

IPO Date

2012-02-13

Stock Exchange

FSX

Ticker

2VSA.F

The Enterprise Value as of July 2026 (TTM) for Verastem, Inc. (2VSA.F) is 337.89M

According to Verastem, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 337.89M. This represents a change of -23.19% compared to the average of 439.88M of the last 4 quarters.

Verastem, Inc. (2VSA.F) Historical Enterprise Value (quarterly & annually)

How has 2VSA.F Enterprise Value performed in the past?

The mean historical Enterprise Value of Verastem, Inc. over the last ten years is 178.57M. The current 337.89M Enterprise Value has changed 18.82% with respect to the historical average. Over the past ten years (40 quarters), 2VSA.F's Enterprise Value was at its highest in in the June 2021 quarter at 698.56M. The Enterprise Value was at its lowest in in the June 2023 quarter at -8664920.00.

Quarterly (TTM)
Annual

Average

178.57M

Median

153.56M

Minimum

9.08M

Maximum

406.94M

Verastem, Inc. (2VSA.F) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Verastem, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 457.50%

Maximum Annual Enterprise Value = 406.94M

Minimum Annual Increase = -91.28%

Minimum Annual Enterprise Value = 9.08M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2025406.94M194.73%
2024138.07M-3.56%
2023143.17M383.77%
202229.59M-91.28%
2021339.46M20.65%
2020281.35M71.61%
2019163.95M-26.64%
2018223.50M341.64%
201750.61M457.50%
20169.08M-78.37%

Verastem, Inc. (2VSA.F) Average Enterprise Value

How has 2VSA.F Enterprise Value performed in the past?

The current Enterprise Value of Verastem, Inc. (2VSA.F) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

229.39M

5-year avg

211.45M

10-year avg

178.57M

Verastem, Inc. (2VSA.F) Enterprise Value vs. Peers

How is 2VSA.F’s Enterprise Value compared to its peers?

Verastem, Inc.’s Enterprise Value is greater than Formycon AG (253.53M), greater than Zura Bio Limited (128.78M), greater than Heidelberg Pharma AG (90.20M), greater than 4basebio PLC (80.00M), less than Medios AG (426.11M), greater than Stratec SE (330.76M), greater than BRAIN Biotech AG (60.85M), greater than Newron Pharmaceuticals S.p.A. (286.75M), greater than M1 Kliniken AG (317.26M), less than CureVac N.V. (536.23M),

CompanyEnterprise ValueMarket cap
253.53M$312.81M
128.78M$290.00M
90.20M$115.09M
80.00M$91.36M
426.11M$316.27M
330.76M$237.53M
60.85M$60.30M
286.75M$264.23M
317.26M$344.77M
536.23M$879.52M

Build a custom stock screener for Verastem, Inc. (2VSA.F) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Verastem, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Verastem, Inc. (2VSA.F) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Verastem, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Verastem, Inc.'s Enterprise Value?

What is the highest Enterprise Value for Verastem, Inc. (2VSA.F)?

What is the 3-year average Enterprise Value for Verastem, Inc. (2VSA.F)?

What is the 5-year average Enterprise Value for Verastem, Inc. (2VSA.F)?

How does the current Enterprise Value for Verastem, Inc. (2VSA.F) compare to its historical average?